中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
19期
86-88
,共3页
胺碘酮%左心衰衰竭%房颤
胺碘酮%左心衰衰竭%房顫
알전동%좌심쇠쇠갈%방전
Amiodarone%Left heart failure%Atrial fibrilation
目的：对胺碘酮治疗重度左心衰竭并房颤的临床疗效进行分析探讨。方法将我院自2012年3月～2014年3月收治的56例重度左心衰竭并房颤患者进行随机分组治疗。结果实验组患者治疗有效率（92.9％）优于对照组患者（71.4％），对比差异，具有统计学意义，P <0.05；实验组患者收缩压、舒张压、平均动脉压及心率均低于对照组，对比差异具有统计学意义，P <0.05；实验组不良反应发生情况低于对照组，对比差异具有统计学意义，P <0.05。结论重度左心衰竭并房颤行胺碘酮治疗，疗效好，安全性高。
目的：對胺碘酮治療重度左心衰竭併房顫的臨床療效進行分析探討。方法將我院自2012年3月～2014年3月收治的56例重度左心衰竭併房顫患者進行隨機分組治療。結果實驗組患者治療有效率（92.9％）優于對照組患者（71.4％），對比差異，具有統計學意義，P <0.05；實驗組患者收縮壓、舒張壓、平均動脈壓及心率均低于對照組，對比差異具有統計學意義，P <0.05；實驗組不良反應髮生情況低于對照組，對比差異具有統計學意義，P <0.05。結論重度左心衰竭併房顫行胺碘酮治療，療效好，安全性高。
목적：대알전동치료중도좌심쇠갈병방전적림상료효진행분석탐토。방법장아원자2012년3월～2014년3월수치적56례중도좌심쇠갈병방전환자진행수궤분조치료。결과실험조환자치료유효솔（92.9％）우우대조조환자（71.4％），대비차이，구유통계학의의，P <0.05；실험조환자수축압、서장압、평균동맥압급심솔균저우대조조，대비차이구유통계학의의，P <0.05；실험조불량반응발생정황저우대조조，대비차이구유통계학의의，P <0.05。결론중도좌심쇠갈병방전행알전동치료，료효호，안전성고。
Objective Clinical eficacy of amiodarone in the treatment of severe left heart failure and atrial fibrilation were analyzed and discussed.Methods56 patients in our hospital from March 2012 to March 2014 with severe left heart failure and atrial fibrilation were randomly assigned treatment.Results The observation group treatment eficiency (92.9%) was significantly better than the control group(71.4%). The diference was statisticaly significant,P < 0.05;systolic blood pressure,diastolic and mean arterial pressure and heart rate in the observation group were significantly lower than the control group,and the diference was statisticaly significant,P < 0.05;incidence of adverse reactions in the experimental group was significantly lower than the control group,and the diference was statisticaly significant,P < 0.05.Conclusion Amiodarone in treatment of severe left heart failure and atrial fibrilation is efective and safe.
